
Entero Healthcare: Board Re-appoints Directors, Approves Results
Entero Healthcare Solutions Ltd's board approved the re-appointment of Mr. Sujesh Vasudevan, Mr. Rajesh Shashikant Dalal, and Ms. Sandhya Gadkari Sharma as Non-Executive Independent Directors for a second term of five years, effective August 25, 2026, subject to shareholder approval. The board also approved the audited financial results for the quarter and financial year ended March 31, 2026. Additionally, the board approved allotment of 7,240 equity shares to eligible employees under the ESOP 2023 plan and noted the grant of fresh 7,300 employee stock options. The 8th Annual General Meeting is scheduled for August 19, 2026. The company also announced the acquisition of Vishal Surgicals and Vishal Surgicals & Medicals through its subsidiary.
Key Highlights
- Re-appointment of three Non-Executive Independent Directors approved for second term.
- Audited financial results for Q4 and FY26 approved with unmodified opinion.
- 7,240 equity shares allotted to employees under ESOP 2023.
- 8th Annual General Meeting scheduled for August 19, 2026.
- Acquisition of Vishal Surgicals and Vishal Surgicals & Medicals announced.